CYTOO
Erwann Ventre is an experienced Innovation Director at CYTOO, a biotech company focused on muscle disorders, since June 2019. Previously, Erwann held multiple leadership roles at APCure, including Project Leader and R&D Manager, where significant achievements included generating over $15 million in revenue, tripling company revenue in three years, and successfully guiding the first product through early development phases. Erwann's career includes positions as a Postdoctoral Researcher at INSERM U1111 and Associate Scientist in the PLATINE project, contributing to advancements in immunology and cancer therapies. Educational background includes a PhD in Immunology from École normale supérieure de Lyon and master's degrees in Life Science Engineering and Biochemistry and Genetics.
This person is not in any teams
CYTOO
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.